Botulinum Toxin Type A as a Tool for Correcting Capsular Contracture after Reconstructive Breast Surgery

Area of Science:

• Plastic Surgery
• Regenerative Medicine

Background:

• Capsular contracture is a frequent complication following breast reconstruction surgery.
• Current surgical treatments (capsulotomy, capsulectomy) involve significant trauma and reduced quality of life.

Observation:

• Botulinum toxin type A, used for neurological conditions and keloid scars, was explored for capsular contracture.
• A clinical case involved treating Grade IV capsular contracture with incobotulinumtoxin A.

Findings:

• The incobotulinumtoxin A injection procedure was simple, required no anesthesia or inpatient care, and had minimal side effects.
• Within one week of the second injection, the patient experienced decreased symptoms, improved breast shape, and complete resolution of pain.

Implications:

• Botulinum toxin type A presents a potential non-surgical alternative for managing breast reconstruction capsular contracture.
• This treatment may improve patient outcomes and quality of life by avoiding surgical reintervention.